Effect of aversive stimulation on 5-hydroxytryptamine and dopamine metabolism in the rat brain

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 3, 1997, Pages 775-783

  Ge, J ^a   Barnes, N M ^b   Costall, B ^a   Naylor, R J ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

5 Hydroxytryptamine; Diazepam; Dopamine; Locomotor activity; Neurochemical consequence; Ondansetron; Rat brain; Social interaction; Turnover

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DIAZEPAM; HOMOVANILLIC ACID; ONDANSETRON;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSIVE BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; ELECTROCHEMISTRY; ENTORHINAL CORTEX; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY NUCLEUS; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; TEMPORAL CORTEX;

ANIMALS; ANTI-ANXIETY AGENTS; BRAIN CHEMISTRY; CATECHOLAMINES; DIAZEPAM; DOPAMINE; ENVIRONMENT; INDOLES; INTERPERSONAL RELATIONS; LIGHT; MALE; MOTOR ACTIVITY; ONDANSETRON; RATS; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0030867765     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00024-5     Document Type: Article

References (49)

1. Andrews N., Barnes N. M., Steward L. J., West K. E., Cunningham J., Wu P. Y., Zangrossi H., File S. E. A comparison of rat brain amino acid and monoamine content in diazepam withdrawal and after exposure to a phobic stimulus. Br. J. Pharmacol. 109:1993;171-174.
2. Andrews N., File S. E. Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal. A review of supporting neurochemical and behavioural evidence Psychopharmacology (Berlin). 112:1993;21-25.
3. Anton A. H., Sayre D. F. A study of the factors affecting the aluminium oxidetrihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther. 138:1962;360-375.
4. Applegate C. D., Kapp B. S., Underwood M. D., McNall C. L. Autonomic and somatomotor effects of amygdala central n. stimulation in awake rabbits. Physiol. Behav. 31:1983;353-360.
5. Blanchard D. C., Blanchard R. J Innate and conditioned reactions to threat in rats with amygdaloid lesions. J. Comp. Physiol. Psychol. 81:1972;281-290.
6. 3 receptor release dopamine from rat striatal slice. Eur. J. Pharmacol. 155:1981;349-350.
7. Chapman W. P. Physiological evidence concerning the importance of the amygdloid nuclear region in the integration of circulating function and emotion in man. Science. 120:1954;949-950.
8. Chopin P., Briley M. Animal models of anxiety. the effect of compounds that modify 5-HT neurotransmission Trends Pharmacol. Sci. 8:1987;383-388.
9. Claustre Y., Rivy J. P., Dennis T., Scatton B. Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat. J. Pharmacol. Exp. Ther. 238:1986;693-700.
10. Collinge J., Pycock C. J., Taberner P. V. Studies on the interaction between cerebral 5-HT and GABA in the model of action of diazepam in the rat. Br. J. Pharmacol. 79:1983;637-641.
11. Corrodi H., Fuxe K., Lindbrink P., Olson L Minor tranquillizers stress and central catecholamine neurones. Brain Res. 29:1971;1-6.
12. Costall B., Kelly M. E., Naylor R. J., Onaivi E. S. Action of buspirone in a putative model of anxiety in the mouse. J. Pharm. Pharmacol. 40:1988;494-500.
13. Costall B., Kelly M. E., Naylor R. J. A potential involvement of the 5-HT receptors in behavioural responding to an aversive situation? Br. J. Pharmacol. 110:1993;96P.
14. Curzon G., Joseph M. H., Knott P. J. Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J. Neurochem. 19:1972;1967-1974.
15. Deutch A. Y., Tam S. Y., Roth R. H. Footshock and conditioned stress increase 3, 4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res. 333:1985;143-146.
16. Downer J. D. C. Changes in visual gnostic function and emotional behaviour following unilateral temporal lobe damage in the 'split-brain' monkey. Nature. 191:1961;50-51.
17. Dun A. J. Stress-related changes in cerebral catecholamine and brain serotonin and 5-hydroxyindoleacetic acid after footshock stress. Life Sci. 42:1988;1847-1853.
18. Dunn A., Welch J. Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J. Neurochem. 57:1991;1615-1622.
19. Engel J. A., Hiorth S., Svensson K. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Eur. J. Pharmacol. 105:1984;365-368.
20. Fadda F., Argiolas A., Melis M. R. Stress-induced increases in 3, 4-dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in accumbens. Reversed by diazepam Life Sci. 23:1978;2219-2224.
21. File S. E., Hyde J. R. G. Can social interaction be used to measure anxiety? Br. J. Pharmacol. 62:1978;19-24.
22. File S. E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods. 2:1980;219-238.
23. File S. F., Hyde J. R. G. The effects of p-chlorophenylalanine and ethanolanine-o-sulphate in an animal test of anxiety. J. Pharm. Pharmacol. 29:1977;735-742.
24. File E., Zangrossi H Jr., Andrews N. Social interaction and elevated plus-maze tests. Changes in release and uptake of 5-HT and GABA Neuropharmacology. 32:1993;217-234.
25. Gardner C. R., Guy A. P. A social interaction model of anxiety sensitive to acutely administered benzodiazepines. Drug Dev. Res. 4:1984;207-216.
26. Gardner C. R. Pharmacological studies of the role of serotonin in animal models of anxiety. Green A. R. Neuropharmacology of serotonin. 1985;281-325 Oxford University Press, Oxford.
27. Gardner C. R. Recent developments of 5-HT-related pharmacology of animals of anxiety. Pharmacol. Biochem. Behav. 24:1986;1479-1485.
28. Garratt J. C., Crespi F., Mason R., Marsden C. A. Effect of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function. Eur. J. Pharmacol. 193:1991;87-93.
29. Ge J., Barnes N. M., Costall B., Naylor R. J. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats. Br. J. Pharmacol. 103:1991;15P.
30. Giorgi O., Guiseppa M., Biggio G. The anxiolytic β-carboline 2K93423 prevents the stress-induced increase dopamine turnover in the prefrontal cortex. Eur. J. Pharmacol. 134:1987;327-331.
31. Gloor P., Oliver A., Quesney L. F. The role of the amygdala in the expression of psychic phenomena in temporal lobe seizures. Ben-Ari R. The amygdaloid complex. 1981;489-497 Elsevier, New York.
32. Handley S. L., McBlane J. W. 5-HT drugs in animal models of anxiety. Psychopharmacology (Berlin). 112:1993;13-20.
33. Hitchcock J. M., Davis M. Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with potentiated startle paradigm. Behav. Neurosci. 100:1986;11-22.
34. Hoehn-Saric R. Neurotransmitters in anxiety. Arch. Gen. Psychiatry. 39:1982;735-742.
35. Imperato A., Puglisi-Allega S., Zocchi A., Scrocco M. G., Casolini P., Angelucci L. Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not diazepam. Eur. J. Pharmacol. 175:1990;211-214.
36. Iversen S. D. 5-HT and anxiety. Neuropharmacology. 23:1984;1553-1560.
37. Kapp B. S., Frysinger R. C., Gallagher M. Amygdala central nucleus lesions. Effects on heart rate conditioning in the rabbit Physiol. Behav. 23:1979;1109-1117.
38. Lavielle S., Tassin T. P., Thierry A. M. Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurones of the rat. Brain Res. 168:1978;585-594.
39. Le Doux J. E., Iwata J., Cicchetti P., Reis D. J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioural correlates of conditioned fear. J. Neurosci. 8:1988;2517-2529.
40. Le Doux J. E., Cicchetti P., Xagoraris A., Romanski L. M. The lateral amygdaloid nucleus. Sensory interface of the amygdala in fear conditioning J. Neurosci. 10:1990;1062-1069.
41. Lidbrink P., Corrodi H., Fuxe K. Barbiturates and meprobamate. Decreases in catecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress Brain Res. 45:1972;507-525.
42. Marsden C. A. 5-Hydroxytryptamine receptor subtypes and new anxiolytic drugs. An appraisal Psychopharmacology of anxiety. 1989;1-27 Oxford University Press, Oxford.
43. A and 5-HT anxiolytics Psychopharmacology (Berlin). 121:1995;38-56.
44. Pei Q., Zetterstrom T., Fillenz M. Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus. Neuropharmacology. 28:1989;1061-1066.
45. Plaznik A., Tamborska E., Hanptman M., Bidzinski A., Kostowsk W. Brain neurotransmitter systems mediating behavioural deficits produced by inescapable shock treatment in rats. Brain Res. 447:1988;122-132.
46. Reinhard J. R., Bannon M. J., Roth R. H. Acceleration by stress of dopamine synthesis and metabolism in prefrontal cortex. Antagonism by diazepam Naunyn Schmiedebergs Arch. Pharmacol. 308:1982;374-377.
47. Thierry A. M., Tassin J. P., Blank G., Glowinski J. Selective activation of mesocortical DA system by stress. Nature. 263:1976;242-244.
48. Wise C. D., Berger B. D., Stein L. Benzodiazepines. Anxiety-reducing activity by reduction of serotonin turnover in the brain Science. 177:1972;180-184.
49. Wright I. K., Upton N., Marsden C. A. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berlin). 109:1992;338-346.